NDC 43598-548-50 - Propofol Injectable Emulsion
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 43598-548
- Requested NDC
- 43598-548-50
- Package NDCs from labels
- 43598-548-50, 43598-548-21
- Manufacturer
- Dr. Reddy's Laboratories, Inc. | Corden Pharma SPA
- Effective date
- 2022-09-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| propofol - Dr. Reddy's Laboratories, Inc. | Corden Pharma SPA | Dr. Reddy's Laboratories, Inc. | Corden Pharma SPA | 2022-09-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43598-548-21 | Propofol Injectable Emulsion | 20 in 1 CARTON | INJECTION, EMULSION | 20 | 5 | |
| 43598-548-50 | Propofol Injectable Emulsion | 50 mL in 1 VIAL | INJECTION, EMULSION | 50 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43598-548-21 | ML - Milliliter | 43598-548 | 48d53e5f-ca01-4d83-b9ec-d9d002bda2e5 | 1 | 2019-02-13 |
| 43598-548-50 | ML - Milliliter | 43598-548 | a9035187-4f69-4a5d-95d2-42a4dac6bc20 | 1 | 2019-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Refresh Digital PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | 97e83e68-6374-4df4-93f6-d707fc32748d | 2022-11-28 | Warnings | PDC6A3C0OX |
| Refresh Digital | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81 | 2022-11-28 | Warnings | PDC6A3C0OX |
| PROPOFOL | PROPOFOL | Hikma Pharmaceuticals USA Inc. | fdb77e13-f5a7-4c4a-9f8e-338b702239c8 | 2022-11-18 | Warnings, Adverse reactions | 1808224 1808217 1808222 YI7VU623SF |
| Propofol Injectable Emulsion | PROPOFOL INJECTABLE EMULSION | Dr. Reddy's Laboratories, Inc. | 800646b8-83a8-01d9-3dc8-bb2ddcb8570c | 2022-09-30 | Warnings, Adverse reactions | ANDA205067 43598-265-25 43598-265-58 43598-549-52 43598-549-10 43598-548-21 43598-548-50 43598-265-20 43598-549 43598-548 43598-265 43598054850 1808224 1808217 1808222 b4a9147e-dfe3-229a-d8d7-6a84e6449f15 800646b8-83a8-01d9-3dc8-bb2ddcb8570c YI7VU623SF |
| REFRESH OPTIVE | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 7f8d88af-fd3b-4138-af61-f24c59ccebd7 | 2022-09-23 | Warnings | PDC6A3C0OX |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | ebd0839e-2e1d-4e0e-986c-19f1f5c76358 | 2022-09-15 | Warnings | PDC6A3C0OX |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | PDC6A3C0OX |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare CORP | 069460a5-3e9a-428f-b2dc-3405690f4fd7 | 2022-07-25 | Boxed warning, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare Corporation | 55609586-f0b4-42e6-8dd9-cd090afb5dca | 2022-07-21 | Boxed warning, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare Corporation | a69c82da-15ba-4d4d-8d7f-871dc3981eb8 | 2022-07-21 | Boxed warning, Adverse reactions | 241ATL177A |
| Intralipid | I. V. FAT EMULSION | Baxter Healthcare Corporation | dd269651-30e8-43f0-880f-484346eaafeb | 2022-07-21 | Boxed warning, Adverse reactions | 241ATL177A |
| Glycerinum | GLYCERINUM | Hahnemann Laboratories, INC. | e34f8796-85b5-2946-e053-2995a90a251e | 2022-07-08 | PDC6A3C0OX | |
| REFRESH Optive Mega-3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | c5f2b3f2-2071-45bd-a010-67f848bc0233 | 2022-06-30 | Warnings | PDC6A3C0OX |
| Miracle FootCream Lavender | UREA, GLYCERIN, ALOE, DISODIUM EDTA | Aloe Vera Korea Co.,Ltd. | db520c80-2a2a-5eb1-e053-2995a90a5bb4 | 2022-03-28 | Warnings | PDC6A3C0OX |
| Miracle FootCream Lemon | UREA, GLYCERIN, ALOE, DISODIUM EDTA | Aloe Vera Korea Co.,Ltd. | db525c63-29fd-2033-e053-2995a90a56b9 | 2022-03-28 | Warnings | PDC6A3C0OX |
| TOTAL ANDRO BAL | CHOLESTERINUM, DAMIANA, DNA, HYPOTHALAMUS, LECITHIN, PHOSPHORICUM AC, SABAL | White Manufacturing Inc. DBA Micro-West | e0716657-b579-4183-baf6-8d554f9bf1bb | 2021-01-21 | Warnings | 1Z74184RGV |
| TOTAL TRI-ESTRO | ADRENALINUM, CIMICIFUGA, IGNATIA, LECITHIN, NICOTINAMIDUM, OOPHORINUM, SEPIA. | White Manufacturing Inc. DBA Micro-West | d3a5e7b6-a4d2-406e-b837-600a886b0ff4 | 2021-01-21 | Warnings | 1Z74184RGV |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare Corporation | cbd3396e-6b85-41bf-82d2-940beba86686 | 2019-01-09 | Boxed warning, Warnings, Adverse reactions | 241ATL177A |
| Ivy-Dry Super | BENZYL ALCOHOL, CAMPHOR, MENTHOL | Ivy-Dry, Inc. | 4792a667-2378-4b3d-968d-9efb1866792f | 2017-12-27 | Warnings | LKG8494WBH |
| Homeoplex D | GLYCERINUM, PHYTOLACCA DECANDRA, TARAXACUM OFFICINALE, ARSENICUM ALBUM, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETYLSALICYLICUM ACIDUM, GLONOINUM, INSULINUM (SUIS), LITHIUM CARBONICUM, THYROIDINUM (SUIS), SALICYLICUM ACIDUM, ADRENOCORTICOTROPHIN, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, SORBITOL, RESORCINUM, BENZYL ALCOHOL, LACTICUM ACIDUM, ISOPROPYL PALMITATE, BORICUM ACIDUM, ACETICUM ACIDUM, | Supplement Clinic, LLC. | cd6b48ab-3566-484d-8deb-15ef6f8e7e8f | 2017-11-01 | Warnings | PDC6A3C0OX LKG8494WBH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.